Palermo’s 2019 research compared 26 postmenopausal women with primary hyperparathyroidism with a group of 31 age- and body mass index-matched controls and reported a significant decrease in irisin concentration in postmenopausal women with primary hyperparathyroidism [145]. The gene discussed is FNDC5; the disease is primary hyperparathyroidism.